NYSE$CNMD

Conmed Corp. · Q4 2019 earnings

Q4 2019 earnings · · Investor relations

Briefing

CONMED Corporation announced financial results for the fourth quarter and full year ended December 31, 2019.

CONMED Corporation reported its Q4 2019 earnings, highlighting the introduction of innovative new products and the successful integration of the Buffalo Filter acquisition. The company increased its investment in its sales organization during the quarter, strengthening its foundation for revenue and profitability growth.

  • Introduced a broad range of innovative new products.
  • Completed the successful integration of the Buffalo Filter acquisition.
  • Increased investment in the sales organization during the fourth quarter.
  • Strengthened foundation for sustainable near- and long-term revenue and profitability growth.

Headline financials

Total Revenue

$265M

Previous: $242M+9.2%
EPS (adj)

$0.90

Previous: $0.73+23.3%
Capital Expenditures

$6.19M

Previous: $4.76M+30.2%
Free Cash Flow

$34.7M

Previous: $19.9M+73.9%
Net Income

$14.9M

Previous: $15.7M-4.6%
Operating Income

$27.9M

Previous: $25.8M+8.0%
Gross Profit

$142M

Previous: $133M+7.0%
Cash & Equivalents

$25.9M

Previous: $17.5M+47.7%
Total Assets

$1.78B

Previous: $1.37B+29.7%
Stock-Based Comp

$2.96M

Previous: $2.57M+15.1%

Revenue & EPS history

Conmed · Revenue · Quarterly

$265M

Q4 2019+9.2%vs Q4 2018
Beat estimate in 13 of 16 quarters(81%)
ActualEstimate

Revenue by segment

Conmed · $277M total across 2 segments · Q2 2022

  • General Surgery
    $157M
  • Orthopedic Surgery
    $120M

Forward guidance

The Company expects 2020 organic constant currency sales growth between 7.0% and 7.5%. The Company also forecasts full-year 2020 adjusted diluted net earnings per share in the range of $3.08 to $3.13.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2019

Historical avgQ4 2019

-0.0%

Avg return

Earnings day

+0.4%

Avg return

5 days after

+3.0%

Avg return

30 days after

45%

29 / 65 earnings

Positive

+16.5%

Q1 2025

Best reaction

-18.5%

Q3 2015

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.6%+1.9%-0.8%
Q4 2025-4.0%+0.3%+18.9%
Q3 2025-0.1%+0.6%-9.8%
Q1 2025+16.5%+13.8%+15.6%
Q4 2024-9.0%-12.1%-15.2%
Q3 2024+5.5%+9.0%+14.5%
Q2 2024-6.0%-5.6%+5.3%
Q1 2024-13.2%-5.7%+3.9%
Q4 2023-11.7%-13.0%-15.7%
Q3 2023-0.3%+3.1%+15.0%
Q2 2023-1.6%+0.8%-10.1%
Q1 2023+11.2%+9.2%+2.7%
Q4 2022+3.3%+6.4%+0.4%
Q3 2022-3.3%-1.0%+3.2%
Q2 2022-2.5%-4.5%-10.0%
Q1 2022-8.5%-19.2%-17.3%
Q4 2021+4.9%+11.0%+19.6%
Q3 2021+1.5%+2.0%-5.9%
Q2 2021+1.3%-0.2%-1.4%
Q1 2021+4.8%+7.0%+1.5%
Q4 2020-4.6%-6.1%+3.1%
Q3 2020+2.8%-3.9%+29.6%
Q2 2020+5.5%-0.4%+4.8%
Q1 2020+9.2%+0.5%+8.5%
Q4 2019-2.6%-4.7%-11.9%
Q3 2019+10.4%+12.9%+13.7%
Q2 2019+7.3%+4.5%+15.3%
Q1 2019+0.7%-2.6%+0.8%
Q4 2018+6.1%+4.9%+12.8%
Q3 2018-0.6%+1.3%+0.8%
Q2 2018+8.6%+5.5%+8.7%
Q1 2018+7.2%+5.3%+10.7%
Q4 2017+10.2%+7.1%+6.3%
Q3 2017+1.9%-2.7%+0.7%
Q2 2017-1.3%+1.3%-4.1%
Q1 2017+4.2%+6.9%+7.6%
Q4 2016-6.9%-4.0%-6.8%
Q3 2016+5.0%+3.3%+18.3%
Q2 2016-17.5%-16.9%-17.0%
Q1 2016-4.1%
Q4 2015-5.9%
Q3 2015-18.5%
Q2 2015-4.3%
Q1 2015+10.7%
Q4 2014-1.4%
Q3 2014+4.4%
Q2 2014-9.5%
Q1 2014-2.8%
Q4 2013+4.2%
Q3 2013-2.7%
Q2 2013+2.8%
Q1 2013-2.7%
Q4 2012+4.6%
Q3 2012+0.3%
Q2 2012-0.4%
Q1 2011+0.8%
Q1 2012-2.1%
Q1 2010-0.2%
Q4 2009-0.2%
Q4 2011-0.2%
Q3 2010-1.8%
Q3 2011-1.8%
Q2 2011-2.3%
Q4 2010-2.3%
Q2 2010-2.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro